Augmedix Inc reports results for the quarter ended in December - Earnings Summary

Augmedix

27/03/2023 14:32

* Augmedix Inc  AUGX.OQ  reported a quarterly adjusted loss
of 15
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 33.1% to $8.75 million from a year ago;
analysts
expected $8.51 million. 
    * Augmedix Inc's reported EPS for the quarter was a loss
of 15
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Augmedix Inc shares had fallen by 3.8% this quarter.
    * The company reported a quarterly loss of $5.6 million.
    * Wall Street's median 12-month price target for Augmedix
Inc is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 27 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.15          Met
 Sep. 30 2022      -0.17                         
 Jun. 30 2022      -0.15          -0.20          Missed
 Mar. 31 2022      -0.15          -0.16          Missed